CRI report

This report describes the general development of China’s pharmaceutical industry in aspects of investment, production, sales, import & export, major prices and operations.

It is estimated that in 2011 the export rare earth products of China exceeded 50,000 tons, whereas the statistics of China Customs was less than 15,000 tons. It means that a mass of rare earth are departed by smuggling.

since 2011, because of the obviously declining batch release of biological products YOY influenced by the implementation of new version GMP, the export amount of biochemical drugs keeps a slow growth rate.

In 2011, the sales revenue of Chinese tire manufacturing enterprises exceeded CNY 400 billion. In recent years, China encounters severe inflation and the prices of tires' raw materials keep rising.

In 2011, the scale of Chinese vaccine market was about CNY 15 billion, while the scale of pharmaceutical industry was about CNY 1.45 trillion in the same period.

China's chain catering industry is still in the primary stage. The standardized construction in most chain catering enterprises is not perfect.

Monoclonal antibody still belongs to high-end products in Chinese market, mainly depending on imports.

By the end of 2011, according to the latest research from CRI, distributors of Chinese automobiles have surpassed 60 thousand.

This report builds on the considerable amount of industry analysis that NanoMarkets has carried out in the BIPV, smart windows and related markets to provide an eight year forecast and roadmap for BIPV products.

Inks and pastes that enable higher resolution printing and miniaturization -The PV market is looking especially troublesome in the coming years, so diversification into other markets will be necessary